Bolaji Samuel

Jul 10, 2024 | biorxiv.org | Bolaji Samuel |DANIEL WEISS |Mathias W. Pletz |Mark Grevsen Martinet

AbstractGiven the high levels of resistance in Gram-negative bacteria, phage therapy is garnering increasing attention. In Germany, a clinical study is already underway investigating a phage cocktail for the treatment of Pseudomonas aeruginosa in cystic fibrosis (CF) patients. In our study, we examined susceptibility to virulent phages and the PF1-like prophage and antimicrobial profiles and of P.